Search Results

There are 22296 results for: content related to: Nondopaminergic mechanisms in levodopa-induced dyskinesia

  1. Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials

    Movement Disorders

    Volume 28, Issue 2, February 2013, Pages: 131–144, Lorraine V. Kalia, Jonathan M. Brotchie and Susan H. Fox

    Article first published online : 5 DEC 2012, DOI: 10.1002/mds.25273

  2. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Article first published online : 27 JUL 2006, DOI: 10.1002/mds.20936

  3. You have free access to this content
    Depletion of Intracellular Glutathione Increases Susceptibility to Nitric Oxide in Mesencephalic Dopaminergic Neurons

    Journal of Neurochemistry

    Volume 73, Issue 4, October 1999, Pages: 1696–1703, Masakazu Ibi, Hideyuki Sawada, Toshiaki Kume, Hiroshi Katsuki, Shuji Kaneko, Shun Shimohama and Akinori Akaike

    Article first published online : 13 JUN 2002, DOI: 10.1046/j.1471-4159.1999.731696.x

  4. You have free access to this content
    The Role of Glutathione in Dopaminergic Neuronal Survival

    Journal of Neurochemistry

    Volume 69, Issue 5, November 1997, Pages: 1850–1858, Ken Nakamura, Wenyi Wang and Un Jung Kang

    Article first published online : 18 NOV 2002, DOI: 10.1046/j.1471-4159.1997.69051850.x

  5. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death

    Journal of Neuroscience Research

    Volume 54, Issue 5, 1 December 1998, Pages: 707–719, Hideyuki Sawada, Masakazu Ibi, Takeshi Kihara, Makoto Urushitani, Akinori Akaike and Shun Shimohama

    Article first published online : 12 DEC 1998, DOI: 10.1002/(SICI)1097-4547(19981201)54:5<707::AID-JNR16>3.0.CO;2-T

  6. An ultrastructural double-label immunohistochemical study of the enkephalinergic input to dopaminergic neurons of the substantia nigra in pigeons

    Journal of Comparative Neurology

    Volume 357, Issue 3, 3 July 1995, Pages: 408–432, Loreta Medina, D. Anderson Keith, J. Karle Ellen and Anton Keiner

    Article first published online : 10 OCT 2004, DOI: 10.1002/cne.903570307

  7. You have free access to this content
    Preferential Resistance of Dopaminergic Neurons to the Toxicity of Glutathione Depletion Is Independent of Cellular Glutathione Peroxidase and Is Mediated by Tetrahydrobiopterin

    Journal of Neurochemistry

    Volume 74, Issue 6, June 2000, Pages: 2305–2314, Ken Nakamura, David A. Wright, Ted Wiatr, Devanand Kowlessur, Sheldon Milstien, Xin Gen Lei and Un Jung Kang

    Article first published online : 18 JAN 2002, DOI: 10.1046/j.1471-4159.2000.0742305.x

  8. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans

    Journal of Comparative Neurology

    Volume 364, Issue 1, 1 January 1996, Pages: 121–150, D.A. McRitchie, C.D. Hardman and G.M. Halliday

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1096-9861(19960101)364:1<121::AID-CNE11>3.0.CO;2-1

  9. Mechanism of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons

    Journal of Neuroscience Research

    Volume 46, Issue 4, 15 November 1996, Pages: 509–518, H. Sawada, S. Shimohama, T. Kawamura, A. Akaike, Y. Kitamura, T. Taniguchi and J. Kimura

    Article first published online : 7 DEC 1998, DOI: 10.1002/(SICI)1097-4547(19961115)46:4<509::AID-JNR13>3.0.CO;2-T

  10. Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system

    Annals of the New York Academy of Sciences

    Volume 1248, Issue 1, February 2012, Pages: 71–88, Marisela Morales and Virginia M. Pickel

    Article first published online : 16 DEC 2011, DOI: 10.1111/j.1749-6632.2011.06299.x

  11. Clinical subtypes of Parkinson's disease

    Movement Disorders

    Volume 26, Issue 1, January 2011, Pages: 51–58, Stephanie M. van Rooden, Fabrice Colas, Pablo Martínez-Martín, Martine Visser, Dagmar Verbaan, Johan Marinus, Ray K. Chaudhuri, Joost N. Kok and Jacobus J. van Hilten

    Article first published online : 16 NOV 2010, DOI: 10.1002/mds.23346

  12. Ultrastructural single- and double-label immunohistochemical studies of substance P-containing terminals and dopaminergic neurons in the substantia nigra in pigeons

    Journal of Comparative Neurology

    Volume 309, Issue 3, 15 July 1991, Pages: 341–362, Dr. Keith D. Anderson, Ellen J. Karle and Anton Reiner

    Article first published online : 9 OCT 2004, DOI: 10.1002/cne.903090305

  13. Plasmalemmal μ-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area

    Synapse

    Volume 41, Issue 4, 15 September 2001, Pages: 311–328, Miguel Garzón and Virginia M. Pickel

    Article first published online : 27 JUN 2001, DOI: 10.1002/syn.1088

  14. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Article first published online : 9 SEP 2008, DOI: 10.1002/mds.22022

  15. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress

    Annals of Neurology

    Volume 44, Issue 1, July 1998, Pages: 110–119, Hideyuki Sawada, Masakazu Ibi, Takeshi Kihara, Makoto Urushitani, Akinori Akaike, Jun Kimura and Dr. Shun Shimohama

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410440117

  16. GABAA receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems

    European Journal of Neuroscience

    Volume 13, Issue 5, March 2001, Pages: 1009–1015, Steven R. Laviolette and Derek Van Der Kooy

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1460-9568.2001.01458.x

  17. Milestones in Parkinson's disease therapeutics

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 1072–1082, Olivier Rascol, Andres Lozano, Matthew Stern and Werner Poewe

    Article first published online : 27 MAY 2011, DOI: 10.1002/mds.23714

  18. Prevalence and clinical profile of restless legs syndrome in Parkinson's disease

    Movement Disorders

    Volume 25, Issue 13, 15 October 2010, Pages: 2142–2147, Dagmar Verbaan, Stephanie M. van Rooden, Jacobus J. van Hilten and Roselyne M. Rijsman

    Article first published online : 24 AUG 2010, DOI: 10.1002/mds.23241

  19. Rhinorrhea: A common nondopaminergic feature of Parkinson's disease

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 320–323, Kelvin L. Chou, Robert A. Koeppe and Nicolaas I. Bohnen

    Article first published online : 14 SEP 2010, DOI: 10.1002/mds.23366

  20. Dopaminergic transplantation for parkinson's disease: Current status and future prospects

    Annals of Neurology

    Volume 66, Issue 5, November 2009, Pages: 591–596, C. Warren Olanow, Jeffrey H. Kordower, Anthony E. Lang and Jose A. Obeso

    Article first published online : 18 JUN 2009, DOI: 10.1002/ana.21778